Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec;5(Suppl 7):S1476-S1478.
doi: 10.21037/tcr.2016.12.39.

Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best

Affiliations
Comment

Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best

Yoshio Yamaoka et al. Transl Cancer Res. 2016 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Dr. Graham is a paid consultant and has received research funding from RedHill Biopharma regarding novel H. pylori therapies and is a consultant to BioGaia regarding use of probiotics for H. pylori infections. Professor Yamaoka has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Susceptibility-based plan for a treatment trial using triple therapy, concomitant therapy and bismuth quadruple therapy, preferably all 14-day duration.

Comment on

References

    1. Liou JM, Fang YJ, Chen CC, et al. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2016;388:2355–65. - PubMed
    1. Graham DY, Dore MP. Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther. 2016;14:577–85. - PMC - PubMed
    1. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015;148:719–31. e3. - PMC - PubMed
    1. Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–67. - PMC - PubMed
    1. Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis infection. N Engl J Med. 2015;373:2512–21. - PMC - PubMed

LinkOut - more resources